Boston Scientific Corp. (BSX) is in the Health Care Industry

• Sort by
• View by Content Type

• Abbott, Boston Scientific: Rising Stent Stars

  Mike Huckman submits: Veteran medical device analyst Mike Weinstein at JPMorgan is out with a pretty remarkable research note about the fast-changing market for drug-coated stents. Not too long ago, some had written off the potential for significant growth to resume in sales of the little wire mesh tubes...

  External links 2008-09-18

  Tags: Boston Scientific Corp., Healthcare, Abbott Laboratories Inc., Johnson & Johnson, Medtronic Inc.

• Medical Devices Are Solid Long-Term

  Zacks.com submits: One sector that has kept a promising longer-term outlook is medical devices and supplies. We recently met with Zacks senior analyst Christopher Titus, CFA regarding his outlook on the group, and which companies he would recommend. How has earnings season gone so far? Any...

  External links 2008-08-13

  Tags: Healthcare, AngioDynamics Inc., ArthroCare Corp., C. R. Bard Inc., Becton, Dickinson and Co., Boston Scientific Corp., Hanger Orthopedic Group Inc.

• IHI: Medical Devices Make a Momentum Comeback

  Don Dion submits: In the last few months of tough stock-market sledding, one of the tried-and-true axioms of investing has come to the forefront: The health care sector is a good place to hide during bear markets. Over the last three months (through Aug. 8), seven funds...

  External links 2008-08-13

  Tags: Healthcare, Boston Scientific Corp., Intuitive Surgical Inc., Medtronic Inc., St. Jude Medical Inc., Thermo Fisher Scientific Inc., Varian Medical Systems Inc., Waters Corp., Zimmer Holdings Inc.

• Bar Coding Helps Boston Scientific 'Error-Proof' Medical Device Packaging

  Boston Scientific Corp., one of the world's largest manufacturers of medical devices, has implemented a new solution for automatically identifying its products prior to packaging. With bar code scanning and a vision inspection system, the company is able to assure that its balloon and stent delivery catheters are correctly packaged...

  White papers 2003-06-01

  Tags: Boston Scientific Corp., AllBusiness.com, Medical Device, Vision, Healthcare, Strategy, Management

Additional Resources

• Wall Street News Alert: Stocks in Focus for Wednesday! October 8, 2008

  Wall Street News Alert's "stocks to watch" thismorning are: Performance Health Technologies, Inc. (OTCBB: PFMH), BostonScientific Corporation (NYSE: BSX), PerkinElmer, Inc. (NYSE: PKI) andAbbott (NYSE: ABT). To receive FREE Mobile Stock Alerts formatted especially for your cellphone, text the word "press" in the subject line to 79704. *** This free...

  Articles 2008-10-08

• Paragon Intellectual Properties Restructures Company to Form Nexeon MedSystems, Inc

  Company Completes Equity Funding Round of $24 Million; Restructuring Prepares Company for Product Commercialization CHARLESTON, W.Va. & CARLSBAD, Calif. -- Paragon Intellectual Properties, LLC, today announced that it has restructured the company, moving from a limited liability company with seven subsidiaries to a single C-corporation to...

  Articles 2008-10-07

• Solos Endoscopy and Its Products Appear in Worldwide Global Endoscopic Systems Market Report

  BOSTON, Oct. 2 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has been included in "High Growth Forecasted for the World Endoscopy Systems Market," a report released on September 4, 2008 in the Reportliner.com catalog. Solos Endoscopy is identified in the report,...

  Articles 2008-10-02

• BellwetherReport.com Analyst Opinions on CY, BSX, LDK and PDX

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...

  Articles 2008-10-01

• SectorWatch.biz Issues MarketStats on NWCI, ERES, STJ, MDT, BSX, and CSCX

  IRVINE, Calif., Oct. 1 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats for health care technology equities in the news and driving markets today. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles, blogs and opinions. Investors can view...

  Articles 2008-10-01

• Boston Scientific Announces Court Decision

  NATICK, Mass., Oct. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation announced today that the United States District Court in Delaware has entered judgment against the Company in a case involving a patent owned by Johnson & Johnson and Boston Scientific's NIR stent product. In the judgment, the...

  Articles 2008-10-01

• U.S. District Court in Delaware Enters Final Judgment of Approximately $1.2 Billion to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation

  MIAMI LAKES, Fla., Sept. 30 /PRNewswire/ -- The U.S. District Court in Delaware today entered final judgment including accrued interest, totaling approximately $1.2 billion, to Cordis Corporation against Medtronic, Inc. and Boston Scientific Corporation in cases involving the original Palmaz balloon expandable stent patent. Juries in 2000 and...

  Articles 2008-09-30

• CryoCath Announces Settlement of Pending Suits with CryoCor, Inc. and AMS Research Corp

  www.cryocath.com Toronto Stock Exchange Symbol: CYT MONTREAL, Sept. 25 /PRNewswire-FirstCall/ -- CryoCathR Technologies Inc. (TSX: CYT.TO) announced today that it has resolved all outstanding patent suits among the company and Boston Scientific Corporation , its wholly-owned subsidiary, CryoCor, Inc., and CryoCor's co-plaintiff/co-defendant AMS Research Corporation. The companies...

  Articles 2008-09-25

• Angiotech's corporate partner, Boston Scientific, announces FDA approval of TAXUS® Express™ Atom™ Stent System, first drug-eluting stent for small vessels

  VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. ("Angiotech") , a global specialty pharmaceutical and medical device company, today reported that its corporate partner, Boston Scientific Corporation , has received U.S. Food and Drug Administration FDA approval to market its TAXUSR Express(2)TM AtomTM Paclitaxel-Eluting Coronary Stent System. The TAXUS...

  Articles 2008-09-25

• Seven Summits Research Releases Comments on XOM, BSX, DAI, GME, and RHT

  CHICAGO, Sept. 25 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at: http://www.go7now.com/nb/0925Y (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven...

  Articles 2008-09-25

• Boston Scientific Announces FDA Approval of TAXUS® Express2™ Atom™ Stent System, First Drug-Eluting Stent For Small Vessels

  Company also announces FDA approval of TAXUSR Express2TM Stent System for treatment of in-stent restenosis NATICK, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has received approval from the U.S. Food and Drug Administration FDA to market its TAXUSR Express2TM AtomTM Paclitaxel-Eluting...

  Articles 2008-09-25

• Zacks Analyst Interview Highlights: Abbott Labs, Amgen, Johnson & Johnson and Boston Scientific

  CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Jason Napodano, who discusses Abbott Labs (NYSE: ABT), Amgen (Nasdaq: AMGN), Johnson & Johnson (NYSE: JNJ) and Boston Scientific (NYSE: BSX). Get the most recent insight from Zacks Equity Research with the free Profit...

  Articles 2008-09-22

• Research and Markets: A Detailed Company Analysis of Boston Scientific Corporation: Providing a Medical Equipment Share Analysis & Valuable Company Data

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/0e4a75/boston_scientific) has announced the addition of the "Boston Scientific Corporation Medical Equipment Company Share Analysis" company profile to their offering. This report is an essential source for data, analysis and strategic insight into Boston Scientific Corporation. The report provides key information relating...

  Articles 2008-09-19

• Boston Scientific to Participate in UBS Global Life Sciences Conference

  NATICK, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22 - 25 in New York City. Jim Tobin, Boston Scientific Chief Executive Officer, will make a 30-minute presentation which will...

  Articles 2008-09-19

• Boston Scientific's divested divisions have a new name

  Boston Scientific's former fluid management and vascular access businesses announced a new name in early August. The new company, acquired in February by private-equity firm Avista Capital Partners, is called Navilyst Medical. "Navilyst Medical combines the best attributes of an established medical device company--market-leading technology, superior clinical data,...

  Articles 2008-09-01

• Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008

  Company to present data from landmark SYNTAX clinical trial NATICK, Mass., Aug. 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced the schedule of the Company's major events and press announcements at the European Society of Cardiology Congress 2008, which runs from August 30 to September 3...

  Articles 2008-08-26